Logistics of Circulating Tumor Cells in Peripheral Blood Collection in Patients with Metastatic Prostate Cancer

Logistics of Circulating Tumor Cells in Peripheral Blood Collection in Patients with Metastatic Prostate Cancer - Logistics CTC in prostate cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40759

Enrollment

Registered

2014-04-16

Start date

2014-04-01

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gemetastaseerd prostaatkanker metastatic prostate cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Male aged 18 years or older Metastatic prostate cancer with a PSA >5ug/L Written informed consent

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
The diagnostic accuracy of Detektor CANCER02 in comparison to Detektor CANCER01 for the detection of CTCs in peripheral blood stream in patients with advanced PC.	—

Secondary

Measure	Time frame
None	—

Countries

Netherlands

Outcome results